Search Orphan Drug Designations and Approvals
-
Generic Name: | N-[4-[[2-(1,1-Dimethylethyl)phenyl]sulfonyl]phenyl]-2,3,4-trihydroxy-5-[[2-(1-methylethyl)phenyl]methyl]benzamide |
---|---|
Date Designated: | 09/14/2020 |
Orphan Designation: | Treatment of retinoblastoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Oxular Ltd Magadalen Centre 1 Robert Robinson Avenue Oxford OX4 4GA United Kingdom The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-